European Journal of Haematology sep'18

Home Care of Acute Leukemia Patients: from Active Therapy to End‐of‐Life and Palliative Care....

European Journal of Hematology Fecha de publicación: 22 february 2019 DOI: https://doi.org/10.1111/ejh.13224 Autores: Isabella Capodanno, Enrica Tamagnini, Pierluigi Alfieri, Katia Codeluppi, Stefano Luminari, Francesco Merli, et al. Background: The aim of...
American Journal of Hematology sep'18

IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes

American Journal of Hematology Fecha de publicación: 21 december 2019 DOI: https://doi.org/10.1002/ajh.25385 Autores: Hong Fang Kaaren K. Reichard Kari G. Rabe Curtis A. Hanson Timothy G. Call Wei Ding Saad...
American Journal of Hematology sep'18

IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes

American Journal of Hematology Fecha de publicación: 21 december 2018 DOI: https://doi.org/10.1002/ajh.25385 Autores: Hong Fang, Kaaren K. Reichard, Kari G. Rabe, Curtis A. Hanson, Timothy G. Call, Wei Ding,...
European Journal of Haematology sep'18

Allogeneic hematopoietic stem cell transplantation in r/r Hodgkin lymphoma after treatment with checkpoint inhibitors:...

European Journal of Hematology Fecha de publicación: 20 october 2018 DOI: https://doi.org/10.1111/ejh.13186 Autores: Reyad Dada, Binyam Usman Background: Relapsed cHL patients after autologous hematopoietic stem cell transplantation (HSCT) with treatment‐sensitive disease are...
The Lancet Hematology

Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up...

The Lancet Haematology Fecha de publicación: 1 november 2018 DOI: https://doi.org/10.1016/S2352-3026(18)30155-8 Autores: Prof Takashi Watanabe, MD., Kensei Tobinai, MD., Masashi Wakabayashi, MSc., Yasuo Morishima, MD., Hirofumi Kobayashi, MD., Tomohiro Kinoshita, MD et al. Background: Standard treatment for untreated...
The Lancet Haematology

Tyrosine kinase inhibitor therapy or transplant in children with Philadelphia chromosome-positive acute lymphoblastic leukaemia:...

The Lancet Haematology Fecha de publicación: 1 december 2018 DOI: https://doi.org/10.1016/S2352-3026(18)30181-9 Autores: Oliver Ottmann Background: Before the advent of tyrosine kinase inhibitor (TKI) therapy, Philadelphia chromosome-positive acute lymphoblastic leukaemia had an exceptionally...
Alimentary Pharmacology and Therapeutics

Response to treatment is more important than disease severity at diagnosis for prediction of...

Alimentary Pharmacologics and Therapeutics Fecha de publicación: 18 november 2018 DOI: https://doi.org/10.1111/apt.15016 Autores: Tomer Ziv‐Baran, Séamus Hussey, Malgorzata Sladek, Jorge Amil Dias, Javier Martin de Carpi, Erasmo Miele, Gabor Veres,...
American Journal of Hematology sep'18

Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic‐phase chronic myeloid leukemia...

American Journal of Hematology Fecha de publicación: 5 october 2018 DOI: https://doi.org/10.1002/ajh.25306 Autores: Rüdiger Hehlmann, Jorge E. Cortes, Teresa Zyczynski, Carlo Gambacorti‐Passerini, Stuart L. Goldberg, Michael J. Mauro, Mauricette Michallet,...